GlobeStar Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $1,864,370.

Profit Margin

GlobeStar Therapeutics Corporation (OTC:GSTC): Profit margin
2014 97.25K -1.24M -1280.35%
2015 42.15K -1.08M -2575.53%
2016 0 -3.29M
2017 0 -1.67M
2018 890 -816.74K -91768.65%
2019 425 -1.03M -243631.76%
2020 77 -779.79K -1012715.58%
2021 0 -9.66M
2022 0 -1.64M
2023 0 -1.94M

GSTC Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
000774258900042.15K97.25K
Cost of revenue
002.41K37.68K1542070017.64K20.21K
Gross profit
00-2.41K-37.60K2716830024.51K77.03K
Operating exp.
Research and development
0000000000
Selling and marketing
0000000155.10K00
Total operating expenses
1.86M1.26M9.09M266.06K316.14K351.73K460.90K155.48K588.42K532.98K
Operating income
-1.86M-1.26M-9.09M-303.67K-315.87K-351.05K-460.90K-155.48K-697.74K-457.56K
Other income (expenses), net
-84.87K-222.74K-707.39K-238.06K-359.20K-362.19K-1.21M-3.13M-387.91K-787.60K
Income before tax
-1.94M-1.48M-9.80M-541.73K-675.07K-816.74K-1.67M-3.29M-1.08M-1.24M
Income tax expense
0152.39K-132.40K238.06K360.36K-258.70K635.68K150.17K387.91K787.60K
Net income
-1.94M-1.64M-9.66M-779.79K-1.03M-816.74K-1.67M-3.29M-1.08M-1.24M
Earnings per share
Basic EPS
-0.00-0.00-0.02-0.00-0.00-0.01-0.04-0.12-0.66-7.5
Diluted EPS
-0.00-0.00-0.02-0.00-0.00-0.01-0.04-0.12-0.66-7.5
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source